NCT01339728

Brief Summary

The purpose of the present study was to investigate the effect of far-infrared ray at CV12 acupoints area on the skin temperature and skin blood flow of palm central area of right hand, and the correlation between them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 14, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 21, 2011

Completed
Last Updated

April 21, 2011

Status Verified

April 1, 2011

Enrollment Period

6 months

First QC Date

April 14, 2011

Last Update Submit

April 20, 2011

Conditions

Reaction of Far Infrared RayReaction of Skin Temperature

Outcome Measures

Primary Outcomes (1)

  • far-infrared ray on CV12 acupoint area may increase the skin temperature

    Each period was 20 min in duration

Interventions

far-infrared rayPROCEDURE

The duration of far-infrared ray is 20 minutes.

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult volunteers, male or female, ages between 20 and 40 years
  • Neurological and physical examination without abnormal functions
  • Far-infrared ray illumination without allergic reaction and contra- indication
  • The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

You may not qualify if:

  • People less than 20 years of age or more than 40 years
  • Women in pregnant or lactating
  • People with mental or behavioral anomalies could not follow the researchers
  • People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
  • People suffered from limb edema and serious skin diseases
  • People did not sign a letter of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 404, Taiwan

Location

Study Officials

  • Ching-Liang Hsieh, professor

    China Medical University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 14, 2011

First Posted

April 21, 2011

Study Start

October 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

April 21, 2011

Record last verified: 2011-04

Locations

TW(1)